Clinical Trial

A Study of CDX-622 in Participants With Mild to Moderate Asthma

Name: A Study of CDX-622 in Participants With Mild to Moderate Asthma — clinical trial record (NCT07330778)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This is a study to determine the safety, pharmacodynamics (PD), and pharmacokinetics (PK) of CDX-622 in adults with mild to moderate asthma.

Protocol Amendment History 7 amendments

This ClinicalTrials.gov record has been amended 7 times since 2026-01-05; most recent amendment 2026-06-30.

Status change: Not Yet Recruiting → Recruiting 2026-01-21

Trial Details

NCT Number	NCT07330778
Lead Sponsor	Celldex Therapeutics
Conditions	Mild to Moderate Asthma
Enrollment	12 participants
Start Date	2026-06-01
Primary Completion	2027-03 (estimated)
Study Completion	2027-03 (estimated)
Updated on ClinicalTrials.gov	2026-07-02